NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/05/2025
Voltar para busca
Dado oficial do USPTO
ARGULIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ARGULIN
ST13
US500000097160775Classe
5, 35, 42, 44
Pedido
97160775
Registro
7805944
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
30/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42, 44
Data de depósito
07/12/2021
Data de registro
27/05/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/05/2025
Última transação
30/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
09
Localização do titular
Zürich, CH
Examinador
KON, ELISSA
Unidade examinadora
L60
Localização atual
PETITIONS OFFICE
Titulares e representantes
Titulares
Kyon Biotech AG
Representantes
Cassandra L. Wilkinson Head, Johnson, Kachigian & Wilkinson, PC
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for cancer treatmentexcluding for treatment of blood cancers; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of obesity; medical and veterinary preparationsanticancer drugs and compounds for treating cancerexcluding for treatment of blood cancersanti-diabetic pharmaceuticals and preparationsanti-obesity pharmaceuticals and preparations
Classe 35
Providing consumer information services relating to the selection of medical products
Classe 42
Medical and pharmacological research services; research on the subject of pharmaceuticals; scientific investigations for medical purposes; scientific research for medical purposes; development of pharmaceutical preparations and medicines
Classe 44
Medical services; medical services in the field of oncology; medical diagnostic testing services; medical clinic services; conducting of medical examinations; medical consultation regarding use and effectiveness of medical products; medical information; medical advisory services; medical analysis servicesmedical analysis services for cancer diagnosis and prognosis; medical services in the field of diabetes; medical care
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
27/05/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
05/05/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/05/2025
PC.D
PETITION TO DIRECTOR DISMISSED
05/05/2025
APET
ASSIGNED TO PETITION STAFF
01/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/03/2025
EX3G
SOU EXTENSION 3 GRANTED
27/03/2025
EXT3
SOU EXTENSION 3 FILED
27/03/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
26/03/2025
EEXT
SOU TEAS EXTENSION RECEIVED
26/03/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/09/2024
EX2G
SOU EXTENSION 2 GRANTED
13/09/2024
EXT2
SOU EXTENSION 2 FILED
13/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
13/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/02/2024
EX1G
SOU EXTENSION 1 GRANTED
19/02/2024
EXT1
SOU EXTENSION 1 FILED
19/02/2024
EEXT
SOU TEAS EXTENSION RECEIVED
19/02/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
27/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/12/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26/09/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
12/08/2023
OP.T
OPPOSITION TERMINATED NO. 999999
12/08/2023
OP.D
OPPOSITION DISMISSED NO. 999999
12/08/2023
CHPB
POST PUBLICATION AMENDMENT - ENTERED
27/07/2023
APET
ASSIGNED TO PETITION STAFF
25/07/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
21/07/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
13/07/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
21/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/01/2023
PUBO
PUBLISHED FOR OPPOSITION
24/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/12/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
19/12/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/12/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
19/12/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/12/2022
DMCC
DATA MODIFICATION COMPLETED
15/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2022
ALIE
ASSIGNED TO LIE
10/12/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/10/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/09/2022
GNSL
LETTER OF SUSPENSION E-MAILED
13/09/2022
CNSL
SUSPENSION LETTER WRITTEN
13/09/2022
DOCK
ASSIGNED TO EXAMINER
13/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/12/2021
NWAP
NEW APPLICATION ENTERED
10/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ARGULIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.